Cite
MLA Citation
H Tan et al.. “Dose Response and Pharmacokinetics of Tofacitinib (CP‐690, 550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis.” CPT: pharmacometrics & systems pharmacology, vol. 2, 2013, pp. 1–8. http://access.bl.uk/ark:/81055/vdc_100048134967.0x000001